Analyst Ratings For Array BioPharma (NASDAQ:ARRY)
Today, Piper Jaffray Companies set its price target on Array BioPharma (NASDAQ:ARRY) of per share.
There are 1 hold rating, 6 buy ratings on the stock.
The current consensus rating on Array BioPharma (NASDAQ:ARRY) is Buy (Score: 2.86) with a consensus target price of $11.86 per share, a potential 39.50% upside.
Some recent analyst ratings include
- 7/18/2017-Cantor Fitzgerald Reiterated Rating of Buy.
- 5/3/2017-J P Morgan Chase & Co Upgrade from a “Neutral ” rating to a ” Overweight” rating.
- 1/30/2017-Leerink Swann was Downgraded by analysts at Leerink Swann from a “Outperform ” rating to a ” Market Perform” rating. They now have a $11.00 price target on the stock.
Recent Insider Trading Activity For Array BioPharma (NASDAQ:ARRY)
Array BioPharma (NASDAQ:ARRY) has insider ownership of 2.60% and institutional ownership of 97.88%.
- On 3/28/2017 Charles M Baum, Director, sold 25,000 with an average share price of $9.27 per share and the total transaction amounting to $231,750.00. View SEC Filing
- On 9/28/2016 Redmile Group, Llc, Major Shareholder, sold 2,492,578 with an average share price of $6.36 per share and the total transaction amounting to $15,852,796.08. View SEC Filing
- On 9/15/2016 Redmile Group, Llc, Major Shareholder, bought 400,000 with an average share price of $3.51 per share and the total transaction amounting to $1,404,000.00. View SEC Filing
- On 1/20/2016 Redmile Group, Llc, Major Shareholder, bought 300,000 with an average share price of $3.19 per share and the total transaction amounting to $957,000.00. View SEC Filing
- On 1/12/2016 Redmile Group, Llc, Major Shareholder, bought 75,000 with an average share price of $3.60 per share and the total transaction amounting to $270,000.00. View SEC Filing
- On 1/11/2016 Redmile Group, Llc, Major Shareholder, bought 925,000 with an average share price of $3.67 per share and the total transaction amounting to $3,394,750.00. View SEC Filing
- On 10/1/2015 Redmile Group, Llc, Major Shareholder, bought 782,592 with an average share price of $4.58 per share and the total transaction amounting to $3,584,271.36. View SEC Filing
Recent Trading Activity for Array BioPharma (NASDAQ:ARRY)
Shares of Array BioPharma closed the previous trading session at 8.50 down -0.01 -0.12% with 2,281,965 shares trading hands.